TYRATyra Biosciences, Inc.
NAS · US · Healthcare · Biotechnology · tyra.bio
29.92USD-10.02%Mkt Cap: 1.80B USDP/E: Last update: 2026-06-01

Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platfo…

Indicators:|

Key Statistics

Company
Market Cap1.80B USD
Enterprise Value1.61B USD
Revenue (TTM)
Gross Profit
Net Income (TTM)-119.95M USD
Revenue/Share
Last Price29.92 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees87
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-11.77
PEG
EV/EBITDA-11.30
EV/Revenue
P/S
P/B6.92
EPS (TTM)-2.18
EPS (Forward)-2.84
52W Range
8.88066% of range40.65
52W High40.65 USD
52W Low8.880 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-46.28%
ROA-42.44%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-95.14M USD
CapEx (TTM)141.00K USD
FCF Margin
FCF Yield-3.34%
Net Debt-377.77M USD
Net Debt/EBITDA2.65
Balance Sheet
Debt/Equity0.02
Current Ratio20.49
Quick Ratio20.05
Book Value/Sh4.826 USD
Cash/Share6.448 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)51.15 USD
Target Range37.00 USD59.62 USD
# Analysts11
Ownership
Shares Out.59.47M
Float30.88M
Insiders2.86%
Institutions111.40%
Short Interest
Short Ratio8.8d
Short % Float25.07%
Short % Out.13.56%
Shares Short8.07M
Short (prev mo.)7.71M
Technical
SMA 5035.59 (-15.9%)
SMA 20025.05 (+19.4%)
Beta0.79
S&P 52W Chg27.70%
Avg Vol (30d)756.78K
Avg Vol (10d)747.27K
Technical Indicators
RSI (14)44.5
MACD-0.6496
MACD Signal-0.4938
MACD Hist.-0.1557
BB Upper36.81 USD
BB Middle34.18 USD
BB Lower31.54 USD
BB Width15.42%
ATR (14)1.834 USD
Vol Ratio (20d)0.68x